SCHEMBL4698029

SCHEMBL4698029

CCCOC(C)CNc1ncnc2oc(-c3ccccc3)c(-c3ccc(OC)cc3)c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 6/20 0.62
CHEK1 O14757 3/20 0.60
CDK1 P06493 1/20 0.60
TNK2 Q07912 4/20 0.59
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
RAD52 P43351 3/20 0.56
POLB P06746 2/20 0.56
KDM4E B2RXH2 3/20 0.56
ALDH1A1 P00352 3/20 0.56
HPGD P15428 3/20 0.56
UBE2N P61088 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPSR1 Q6W5P4 2/20 0.53
HSD17B10 Q99714 2/20 0.53
LMNA P02545 1/20 0.53
PKM P14618 1/20 0.53
TSHR P16473 1/20 0.53
EGFR P00533 2/20 0.53
LCK P06239 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6750848 0.90 AURKA (0.60) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL4527849 0.90 AURKA (0.60) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL6750876 0.88 AURKA (0.58) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL4530921 0.88 AURKA (0.58) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL4519943 0.86 AURKA (0.84) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL6749226 0.86 AURKA (0.84) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL6749207 0.86 AURKA (0.84) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL4788792 0.83 KDM4E (0.58) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL6748503 0.81 CHEK1 (0.77) AURKACHEK1CDK1TNK2KMT2A
SCHEMBL4696929 0.81 KMT2A (0.73) AURKACHEK1CDK1TNK2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008131858-A2 USE OF ACYCLICALLY SUBSTITUTED FUROPYRIMIDINE DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTONIA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-11-06 WO disclosed
EP-1966217-A1 NOVEL, ACYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2008-09-10 EP disclosed
WO-2007079862-A1 NOVEL, ACYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2007-07-19 WO disclosed